Protein Official symbol | IDH2 |
Aliases | IDH2 |
Chromosomal Location | 15 |
Length | 452 |
Uniprot ID | P48735 |
EC number | 1.1.1.42 |
Protein family Information(Pfam) | PF00180; |
PDB id | 4JA8;5GIS;5I95;5I96;5SVN;5SVO;6ADI;6VFZ; |
InterPro ID | IPR019818;IPR004790;IPR024084; |
dbSNP | rs267606870 rs121913502 rs1057519906 rs121913503 rs121913503 rs1057519736 rs1057519906 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
IDH3B | IDH3A | 0.9990000000000001 |
IDH3A | IDH3G | 0.9990000000000001 |
IDH2 | IDH3G | 0.998 |
IDH3G | ACO2 | 0.998 |
IDH3A | ACO2 | 0.998 |
IDH2 | IDH3A | 0.997 |
IDH3B | IDH2 | 0.997 |
IDH1 | IDH3B | 0.995 |
IDH1 | IDH3G | 0.995 |
GLUD2 | GLUD1 | 0.9940000000000001 |
IDH3B | ACO2 | 0.9940000000000001 |
IDH3B | IDH3G | 0.993 |
MDH2 | GOT2 | 0.993 |
IDH1 | IDH3A | 0.9890000000000001 |
IDH1 | OGDH | 0.987 |
SOD2 | SIRT3 | 0.987 |
IDH2 | OGDH | 0.987 |
GLUD1 | GOT2 | 0.986 |
IDH3A | OGDH | 0.985 |
IDH2 | ACO2 | 0.981 |
IDH1 | ACO2 | 0.9790000000000001 |
GOT1 | GLUD1 | 0.9790000000000001 |
GOT1 | GLUD2 | 0.978 |
SIRT3 | IDH2 | 0.978 |
IDH3B | OGDH | 0.977 |
IDH1 | IDH2 | 0.976 |
OGDH | IDH3G | 0.975 |
OGDHL | IDH3A | 0.9740000000000001 |
GLUD2 | GOT2 | 0.973 |
IDH1 | ACO1 | 0.971 |
IDH2 | ACO1 | 0.97 |
SOD2 | IDH2 | 0.9690000000000001 |
IDH3B | OGDHL | 0.9670000000000001 |
IDH2 | GLUD1 | 0.965 |
GOT1 | MDH2 | 0.9640000000000001 |
OGDHL | IDH3G | 0.963 |
SIRT3 | ACSS2 | 0.963 |
GLUD1 | OGDH | 0.958 |
ACO1 | IDH3A | 0.9570000000000001 |
IDH3B | ACO1 | 0.955 |
IDH2 | GOT2 | 0.955 |
ACO1 | IDH3G | 0.955 |
IDH2 | GLUD2 | 0.9520000000000001 |
IDH1 | GOT2 | 0.95 |
IDH2 | ACSS2 | 0.948 |
MDH2 | GLUD1 | 0.946 |
SIRT3 | GLUD1 | 0.9420000000000001 |
SOD2 | GLUD1 | 0.9420000000000001 |
IDH2 | D2HGDH | 0.941 |
OGDHL | IDH2 | 0.94 |
GOT1 | OGDH | 0.9390000000000001 |
IDH1 | OGDHL | 0.9390000000000001 |
GLUD1 | ACSS2 | 0.937 |
GLUD2 | OGDH | 0.937 |
GLUD2 | MDH2 | 0.937 |
IDH1 | GLUD1 | 0.934 |
SOD2 | GLUD2 | 0.932 |
GOT1 | GOT2 | 0.9309999999999999 |
SOD2 | ACSS2 | 0.929 |
MDH2 | ACO2 | 0.929 |
GLUD2 | ACSS2 | 0.9229999999999999 |
MDH2 | IDH3A | 0.922 |
GOT2 | OGDH | 0.92 |
IDH2 | MDH2 | 0.919 |
SIRT3 | GLUD2 | 0.9179999999999999 |
OGDHL | GLUD2 | 0.917 |
IDH1 | GOT1 | 0.915 |
IDH3A | GLUD1 | 0.914 |
GLUD2 | IDH3A | 0.91 |
IDH1 | MDH2 | 0.91 |
IDH1 | GLUD2 | 0.9059999999999999 |
GLUD2 | IDH3G | 0.903 |
OGDHL | GLUD1 | 0.902 |
GOT1 | IDH2 | 0.9 |
IDH3B | GLUD2 | 0.9 |
# | 3420 (IDH3B) | 3418 (IDH2) | 3421 (IDH3G) | 3417 (IDH1) | 2747 (GLUD2) | 4191 (MDH2) | 6648 (SOD2) | 2746 (GLUD1) | 2805 (GOT1) | 23410 (SIRT3) | 4967 (OGDH) | 55753 (OGDHL) | 48 (ACO1) | 2806 (GOT2) | 50 (ACO2) | 55902 (ACSS2) | 728294 (D2HGDH) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3420 (IDH3B) | 1.00 | 0.21 | 0.19 | 0.28 | 0.21 | 0.21 | 0.28 | 0.34 | 0.21 | 0.34 | 0.21 | 0.34 | 0.34 | 0.21 | 0.21 | 0.18 | 0.23 |
3418 (IDH2) | 0.21 | 1.00 | 0.75 | 0.66 | 0.30 | 0.40 | 0.44 | 0.30 | 0.15 | 0.44 | 0.29 | 0.33 | 0.24 | 0.20 | 0.40 | 0.21 | 0.38 |
3421 (IDH3G) | 0.19 | 0.75 | 1.00 | 0.75 | 0.29 | 0.57 | 0.34 | 0.29 | 0.17 | 0.14 | 0.29 | 0.29 | 0.17 | 0.17 | 0.17 | 0.16 | 0.53 |
3417 (IDH1) | 0.28 | 0.66 | 0.75 | 1.00 | 0.30 | 0.37 | 0.58 | 0.48 | 0.16 | 0.56 | 0.40 | 0.55 | 0.43 | 0.24 | 0.32 | 0.19 | 0.45 |
2747 (GLUD2) | 0.21 | 0.30 | 0.29 | 0.30 | 1.00 | 0.26 | 0.30 | 0.84 | 0.14 | 0.24 | 0.34 | 0.27 | 0.22 | 0.22 | 0.24 | 0.49 | 0.40 |
4191 (MDH2) | 0.21 | 0.40 | 0.57 | 0.37 | 0.26 | 1.00 | 0.29 | 0.30 | 0.16 | 0.27 | 0.31 | 0.34 | 0.49 | 0.59 | 0.19 | 0.20 | 0.43 |
6648 (SOD2) | 0.28 | 0.44 | 0.34 | 0.58 | 0.30 | 0.29 | 1.00 | 0.48 | 0.18 | 0.66 | 0.38 | 0.54 | 0.40 | 0.25 | 0.44 | 0.21 | 0.30 |
2746 (GLUD1) | 0.34 | 0.30 | 0.29 | 0.48 | 0.84 | 0.30 | 0.48 | 1.00 | 0.13 | 0.44 | 0.34 | 0.47 | 0.43 | 0.26 | 0.25 | 0.42 | 0.43 |
2805 (GOT1) | 0.21 | 0.15 | 0.17 | 0.16 | 0.14 | 0.16 | 0.18 | 0.13 | 1.00 | 0.14 | 0.20 | 0.19 | 0.14 | 0.71 | 0.17 | 0.15 | 0.19 |
23410 (SIRT3) | 0.34 | 0.44 | 0.14 | 0.56 | 0.24 | 0.27 | 0.66 | 0.44 | 0.14 | 1.00 | 0.16 | 0.62 | 0.49 | 0.27 | 0.49 | 0.20 | 0.19 |
4967 (OGDH) | 0.21 | 0.29 | 0.29 | 0.40 | 0.34 | 0.31 | 0.38 | 0.34 | 0.20 | 0.16 | 1.00 | 1.00 | 0.20 | 0.20 | 0.20 | 0.18 | 0.40 |
55753 (OGDHL) | 0.34 | 0.33 | 0.29 | 0.55 | 0.27 | 0.34 | 0.54 | 0.47 | 0.19 | 0.62 | 1.00 | 1.00 | 0.48 | 0.28 | 0.26 | 0.17 | 0.31 |
48 (ACO1) | 0.34 | 0.24 | 0.17 | 0.43 | 0.22 | 0.49 | 0.40 | 0.43 | 0.14 | 0.49 | 0.20 | 0.48 | 1.00 | 0.50 | 0.42 | 0.18 | 0.23 |
2806 (GOT2) | 0.21 | 0.20 | 0.17 | 0.24 | 0.22 | 0.59 | 0.25 | 0.26 | 0.71 | 0.27 | 0.20 | 0.28 | 0.50 | 1.00 | 0.20 | 0.21 | 0.26 |
50 (ACO2) | 0.21 | 0.40 | 0.17 | 0.32 | 0.24 | 0.19 | 0.44 | 0.25 | 0.17 | 0.49 | 0.20 | 0.26 | 0.42 | 0.20 | 1.00 | 0.21 | 0.21 |
55902 (ACSS2) | 0.18 | 0.21 | 0.16 | 0.19 | 0.49 | 0.20 | 0.21 | 0.42 | 0.15 | 0.20 | 0.18 | 0.17 | 0.18 | 0.21 | 0.21 | 1.00 | 0.30 |
728294 (D2HGDH) | 0.23 | 0.38 | 0.53 | 0.45 | 0.40 | 0.43 | 0.30 | 0.43 | 0.19 | 0.19 | 0.40 | 0.31 | 0.23 | 0.26 | 0.21 | 0.30 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDH2 | Rat | Kidney | - | 7628 m | 7 day | downregulated | -1.677 | 2-DE | Northern indo-australian plate | Male sprague-dawley | 1 | Male SD rats weighing 250-260g | 30005088 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT007339 | hsa-miR-183-5p | Homo sapiens | IDH2 | 3418 | Homo sapiens | Immunocytochemistry//Luciferase reporter assay//qRT-PCR | Functional MTI | 23263745 |
MIRT029275 | hsa-miR-26b-5p | Homo sapiens | IDH2 | 3418 | Homo sapiens | Microarray | Functional MTI (Weak) | 19088304 |
MIRT052706 | hsa-miR-1260b | Homo sapiens | IDH2 | 3418 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT710701 | hsa-miR-6836-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710703 | hsa-miR-6829-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710705 | hsa-miR-6778-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710709 | hsa-miR-6840-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710707 | hsa-miR-6764-5p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710710 | hsa-miR-1250-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710700 | hsa-miR-498 | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710702 | hsa-miR-5001-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710698 | hsa-miR-7152-5p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710699 | hsa-miR-3074-5p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710708 | hsa-miR-1915-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710706 | hsa-miR-4726-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
MIRT710704 | hsa-miR-6791-3p | Homo sapiens | IDH2 | 3418 | Homo sapiens | HITS-CLIP | Functional MTI (Weak) | 19536157 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
3418 | GO:0006103 | 2-oxoglutarate metabolic process | GOTERM_BP_DIRECT |
3418 | GO:0005975 | carbohydrate metabolic process | GOTERM_BP_DIRECT |
3418 | GO:0005739 | mitochondrion | GOTERM_CC_DIRECT |
3418 | GO:0005777 | peroxisome | GOTERM_CC_DIRECT |
3418 | GO:0005743 | mitochondrial inner membrane | GOTERM_CC_DIRECT |
3418 | GO:0000287 | magnesium ion binding | GOTERM_MF_DIRECT |
3418 | GO:0004450 | hydroxymethylglutaryl-CoA synthase activity | GOTERM_MF_DIRECT |
3418 | GO:0005759 | mitochondrial matrix | GOTERM_CC_DIRECT |
3418 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
3418 | GO:0006099 | tricarboxylic acid cycle | GOTERM_BP_DIRECT |
3418 | GO:0051287 | NAD binding | GOTERM_MF_DIRECT |
3418 | GO:0005829 | cytosol | GOTERM_CC_DIRECT |
3418 | GO:0006097 | glyoxylate cycle | GOTERM_BP_DIRECT |
3418 | GO:0006102 | isocitrate metabolic process | GOTERM_BP_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
3418 | hsa00020 | Citrate cycle |
3418 | hsa00480 | Glutathione metabolism |
3418 | hsa01200 | Carbon metabolism |
3418 | hsa01210 | 2-Oxocarboxylic acid metabolism |
3418 | hsa01100 | Metabolic pathways |
3418 | hsa01130 | Biosynthesis of antibiotics |
3418 | hsa01230 | Biosynthesis of amino acids |
3418 | hsa04146 | Peroxisome |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
IDH2 | 3418 | Hematologic Neoplasms | C0376545 | Neoplastic Process | 0.37 | 0.469 | 0.655 | group |
IDH2 | 3418 | Biliary Tract Neoplasm | C0005426 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Leukemia, Myelocytic, Acute | C0023467 | Neoplastic Process | 0.7 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Cholangiocarcinoma | C0206698 | Neoplastic Process | 0.55 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Glioblastoma Multiforme | C1621958 | Neoplastic Process | 0.52 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Osteoporosis, Age-Related | C0001787 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Hypertrophic Cardiomyopathy | C0007194 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Hydronephrosis | C0020295 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Peripheral T-Cell Lymphoma | C0079774 | Neoplastic Process | 0.34 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Seizures, Clonic | C0234535 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Intrahepatic Cholangiocarcinoma | C0345905 | Neoplastic Process | 0.38 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Chorioangioma | C0677608 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Renal Insufficiency | C1565489 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Extrahepatic Cholangiocarcinoma | C3805278 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Convulsions | C4048158 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Neoplasm Recurrence, Local | C0027643 | Neoplastic Process | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Adult Oligodendroglioma | C0279070 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Vertiginous seizure | C0422855 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Tonic - clonic seizures | C0494475 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Angioimmunoblastic Lymphadenopathy | C0020981 | Neoplastic Process | 0.4 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Seizures, Somatosensory | C0422850 | Pathologic Function | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Olfactory seizure | C0422853 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Convulsive Seizures | C0751494 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Angioma | C1959588 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Epileptic Seizures | C4317109 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Osteoarthrosis Deformans | C0086743 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Oligodendroblastoma | C0344461 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Gustatory seizure | C0422854 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Seizures, Sensory | C0751496 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Acute Myeloid Leukemia, M1 | C0026998 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Tonic Seizures | C0270844 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Visual seizure | C0270824 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Seizures, Focal | C0751495 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Cardiac Hypertrophy | C1383860 | Pathologic Function | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Myoclonic Seizures | C4317123 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Hemangioma | C0018916 | Neoplastic Process | 0.34 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Osteoporosis, Senile | C0029459 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Atonic Absence Seizures | C0751123 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Chondroma | C0936248 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Histiocytoid hemangioma | C0205788 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Combined D-2- and L-2-hydroxyglutaric aciduria | C2746066 | Disease or Syndrome | 0.35 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Generalized Absence Seizures | C4505436 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Ventricular Dysfunction, Left | C0242698 | Pathologic Function | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Childhood Oligodendroglioma | C0280475 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Enchondroma | C1704356 | Neoplastic Process | 0.32 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Osteoporosis | C0029456 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Kidney Failure | C0035078 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Generalized seizures | C0234533 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Single Seizure | C0751110 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Absence Seizures | C4316903 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | CNS disorder | C0007682 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | group |
IDH2 | 3418 | Hemangioma, Intramuscular | C0205789 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Mixed Oligodendroglioma-Ependymoma | C0751395 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Post-Traumatic Osteoporosis | C0751406 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Cardiomegaly | C0018800 | Finding | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Jacksonian Seizure | C0022333 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Seizures | C0036572 | Sign or Symptom | 0.43 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Complex partial seizures | C0149958 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Craniofacial Abnormalities | C0376634 | Congenital Abnormality | 0.3 | 0.469 | 0.655 | group |
IDH2 | 3418 | Epileptic drop attack | C0270846 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Non-epileptic convulsion | C0751056 | Sign or Symptom | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Acute Myeloid Leukemia (AML-M2) | C1879321 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Nonepileptic Seizures | C3495874 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Growth Disorders | C0018273 | Pathologic Function | 0.3 | 0.469 | 0.655 | group |
IDH2 | 3418 | Acute Promyelocytic Leukemia | C0023487 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Degenerative polyarthritis | C0029408 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Seizures, Auditory | C0422852 | Pathologic Function | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Maffucci Syndrome | C0024454 | Disease or Syndrome | 0.55 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Anaplastic Oligodendroglioma | C0334590 | Neoplastic Process | 0.55 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Enchondromatosis | C0014084 | Disease or Syndrome | 0.66 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Mixed Oligodendroglioma-Astrocytoma | C0280793 | Neoplastic Process | 0.51 | 0.469 | 0.655 | disease |
IDH2 | 3418 | oligodendroglioma | C0028945 | Neoplastic Process | 0.6 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Well Differentiated Oligodendroglioma | C0751396 | Neoplastic Process | 0.6 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Cardiomyopathy, Dilated | C0007193 | Disease or Syndrome | 0.31 | 0.469 | 0.655 | group |
IDH2 | 3418 | Congenital anemia | C0158995 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Conduction disorder of the heart | C0264886 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | group |
IDH2 | 3418 | Intellectual Disability | C3714756 | Mental or Behavioral Dysfunction | 0.3 | 0.469 | 0.655 | group |
IDH2 | 3418 | Epileptic encephalopathy | C0543888 | Disease or Syndrome | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Cytopenia | C0010828 | Pathologic Function | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Gemistocytic astrocytoma | C0334581 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Protoplasmic astrocytoma | C0334580 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Anaplastic astrocytoma | C0334579 | Neoplastic Process | 0.36 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Fibrillary Astrocytoma | C0334582 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Anaplastic Oligoastrocytoma | C0431108 | Neoplastic Process | 0.31 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Dyschondroplasias | C0013366 | Congenital Abnormality | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | D-2-HYDROXYGLUTARIC ACIDURIA 1 | C3152055 | Disease or Syndrome | 0.32 | 0.469 | 0.655 | disease |
IDH2 | 3418 | D-2-HYDROXYGLUTARIC ACIDURIA 2 | C3150909 | Disease or Syndrome | 0.4 | 0.469 | 0.655 | disease |
IDH2 | 3418 | GLIOMA SUSCEPTIBILITY 1 | C2750850 | Finding | 0.3 | 0.469 | 0.655 | phenotype |
IDH2 | 3418 | Astrocytoma | C0004114 | Neoplastic Process | 0.4 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Subependymal Glioma | C0206725 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Glioma of Brain, Familial | C1842010 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
IDH2 | 3418 | Ependymoma | C0014474 | Neoplastic Process | 0.3 | 0.469 | 0.655 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
IDH2 | 3418 | AGI-6780 | None | None | None |
IDH2 | 3418 | AG-881 | None | None | None |
IDH2 | 3418 | AG-221 | None | None | None |
IDH2 | 3418 | Dasatinib | DASATINIB | CHEMBL1421 | None |
IDH2 | 3418 | Dasatinib | DASATINIB | CHEMBL1421 | None |
IDH2 | 3418 | Enasidenib | None | None | None |
IDH2 | 3418 | ENASIDENIB | None | None | None |
IDH2 | 3418 | ENASIDENIB (AG-221) | None | None | None |
IDH2 | 3418 | Enasidenib | None | None | None |
IDH2 | 3418 | ENASIDENIB | None | None | inhibitor |
IDH2 | 3418 | OLAPARIB | OLAPARIB | CHEMBL521686 | None |
IDH2 | 3418 | Quizartinib | QUIZARTINIB | CHEMBL576982 | None |
IDH2 | 3418 | Saracatinib | SARACATINIB | CHEMBL217092 | None |
IDH2 | 3418 | Venetoclax | VENETOCLAX | CHEMBL3137309 | None |
IDH2 | 3418 | Venetoclax | VENETOCLAX | CHEMBL3137309 | None |